• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Centogene N.V. (NQ: CNTG )

    0.3250 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Centogene N.V.

    < Previous 1 2 3 4 5 Next >
    CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Receives Delisting Notice From Nasdaq
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
    From Centogene NV
    Via GlobeNewswire
    C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
    From Centogene NV
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are a hot topic on Thursday and we have them covered with our breakdown of all the latest news this morning! 
    Via InvestorPlace
    CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
    Expanding Relationship With Lifera, a Biopharma Company Owned by the PIF 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
    Fueling the diagnosis of over 2,500 rare and neurodegenerative diseases, more than 300 peer-reviewed publications, and 48 pharma collaborations 
    From Centogene NV
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning! 
    Via InvestorPlace
    Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    CENTOGENE Receives Nasdaq Non-Compliance Notice
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
    Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
    Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Explores Strategic Alternatives
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
    Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical Development 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Receives French Research Tax Credit Accreditation
    Partners able to claim up to 30% tax relief 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
    Collaboration to accelerate research to determine role of GBA gene 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Announces Preliminary Full Year 2023 Revenue
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Announces Voting Results of Extraordinary General Meeting
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
    Results From Landmark Study Published in Brain Journal 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
    Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Reports First Half 2023 Financial Results
    Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance 
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
    From Centogene NV
    Via GlobeNewswire
    CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
    From Centogene NV
    Via GlobeNewswire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.